Vasoconstrictor and vasodilator effects of disopyramide on isolated rat vascular smooth muscle

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 5, 1998, Pages 745-752

  Pérez Vizcaíno, Francisco ^a   Fernández, Cristina ^b   Fernández Del Pozo, Buensuceso ^b   Cogolludo, Angel ^a   Zaragozá, Francisco ^b   Tamargo, Juan ^a  

^a Instituto Nacional de Toxicologia   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Aorta; Disopyramide; Portal vein; Rat

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; DISOPYRAMIDE; FURA 2 ACETOXYMETHYL ESTER; LEMAKALIM; NIFEDIPINE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE; SODIUM ION;

ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; HYPOTENSION; INOTROPISM; ISOLATED ARTERY; MALE; MEAN ARTERIAL PRESSURE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM; DISOPYRAMIDE; MALE; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; NOREPINEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0343172816     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199811000-00010     Document Type: Article

References (47)

1. Wharton JM, Hill JN, Freedberg NA, Prytowsky EN. Disopyramide. In: Messerly FH, ed. Cardiovascular drugs and therapy. Philadelphia: WB Saunders, 1996:1273-95.
2. Vaughan Williams EM. Classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24: 129-47.
3. Salata JJ, Wasserstrom JA. Effects of quinidine on action potentials and ionic currents in isolated canine ventricular myocytes. Circ Res 1988;62:324-37.
4. Ca in single frog cardiac cells by quinidine, flecainide, ethmozin and ethacizin. Am J Physiol 1989;256:C549-59.
5. + channel blocking actions of flecainide compared to those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmacol Exp Ther 1994;269:66-72.
6. Delgado C, Tamargo J, Henzel D, Lorente P. Effects of propafenone on calcium currents in guinea-pig ventricular myocytes. Br J Pharmacol 1993;108:721-7.
7. + current in guinea-pig ventricular myocytes: voltage-independent and time-dependent block of the slowly activating component. Circ Res 1995;76:223-35.
8. + current by the class Ia agent disopyramide in cat ventricular myocytes. J Pharmacol Exp Ther 1995;272:714-23.
9. 2+ channels of myocardial cells. Jpn Circ J 1988;52:238-42.
10. 45Ca movements and contractile responses in vascular smooth muscle. Br J Pharmacol 1991:103:1453-7.
11. Pérez-Vizcaíno F, Duarte J, Tamargo J. Effects of flecainide on isolated vascular smooth muscles of rat. Br J Pharmacol 1991;104: 726-30.
12. Pérez-Vizcaíno F. Fernández del Pozo B, Zaragozá, F, Tamargo J. Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine. Br J Pharmacol 1994;113:1281-8.
13. Dohi Y, Masayoshi K, Sato K. Vasorelaxant effect of mexiletine in mesenteric resistance arteries of rats. Br J Pharmacol 1994;111: 673-80.
14. Godfraind T, Miller R, Wibbo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986;38:324-416.
15. Donovan KD, Dobb GJ, Coombs LJ, et al. Efficacy of flecainide for the reversion of acute onset atrial fibrillation. Am J Cardiol 1992;70:50A-5A.
16. Greenspan AM, Webb CR, Spielman SR, Horowitz LN. Intravenous mexiletine therapy for ventricular tachyarrhythmias. Clin Res 1984;32:172A.
17. Koch-Weser J, Klein SW. Procainamide dosage schedules, plasma concentrations and clinical effects. JAMA 1971;215:454-60.
18. Mariano DJ, Schomer SJ, Rea RF. Effects of quinidine on vascular resistance and sympathetic nerve activity in humans. J Am Coll Cardiol 1992;20:1411-6.
19. Boland J, Lisin N, Marcelle R, Carlier J. Effects du disopyramide intraveineux sur l' hémodynamique de patients hospitalisés en unités de soins intensifs. Arch Int Pharmacodyn Ther 1976;224:145.
20. Vismara L. Clinical studies of Norpace (Part II). Angiology 1975;26: 132-6.
21. Brogden RN, Todd PA. Disopyramide: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias. Drugs 1987;34:151-87.
22. Walsh RA, Horwitz LD. Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs. Circulation 1979;60:1053-60.
23. Block PJ, Winkle RA. Hemodynamic effects of antiarrhythmic drugs. Am J Cardiol 1983;52:14C-23C.
24. Kotter V, Linderer T, Schroder R. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine. Am J Cardiol 1980;46:469-73.
25. Befeler B, Castellanos A, Wells DE, Vagueiro MC, Yeh BK. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate. Am J Cardiol 1975;35:282.
26. 2+ signal and contraction in rat aorta. Br J Pharmacol 1995;114:1731-7.
27. Nomura Y, Asano M, Ito K, Uyama Y, Imaizumi Y, Watanabe M. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats. Br J Pharmacol 1997;120:65-73.
28. Sato K, Ozaki H, Karaki H. Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. J Pharmacol Exp Ther 1988;246:294-300.
29. 45Ca influx and net Ca uptake into rabbit aortic smooth muscle. Eur J Pharmacol 1985;116:299-305.
30. Edwards G, Weston AH. Potassium channels in the regulation of vascular smooth muscle tone. In: Godfraind T. Mancia G, Abracchio MP, Aguilar-Bryan L Govoni S, eds. Pharmacological control of calcium and potassium homeostasis. Dordrecht: Kluwer Academic-Publishers, 1995:85-94.
31. Mirro MJ, Watanabe AM, Bailey JC. Electrophysiologic effect of the optical isomers of disopyramide and quinidine in the dog: dependence on stereochemistry. Circ Res 1981;48:867-74.
32. + channels in Xenopus oocytes. Br J Pharmacol 1992;107:1061-7.
33. + channels of mouse skeletal muscle by disopyramide. Eur J Pharmacol 1995;284:35-41.
34. Martin DK, Nakaya Y, Wyse KR, Campbell TJ. Effects of disopyramide and flecainide on the kinetics of inward rectifier potassium channels in rabbit heart muscle. Br J Pharmacol 1994;111:873-9.
35. Coraboeuf E, Derobaix E, Escande D, Coulombe A. Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep Purkinje fibres. Cardiovasc Res 1988;22:375-84.
36. + channels. Kv1.2 and Kv1.4. Eur J Pharmacol 1995;281:151-9.
37. Pérez Vizcaíno F, Casis O, Rodríguez R, Gómez GA, García-Rafanell J. Tamargo J. Effects of the novel potassium channel opener UR-8225 in rat vascular smooth muscle. Br J Pharmacol 1993;110:1165-71.
38. Mikkelsen E. Comparison of effects of a new dihydropyridine, Bay K 8644, and nifedipine on spontaneous mechanical activity in rat portal vein. Br J Pharmacol 1985;85:383-5.
39. Noack T, Edwards G, Deitmer P, et al. The involvement of potassium channels in the action of ciclazindol in rat portal vein. Br J Pharmacol 1992;106:17-24.
40. Bolton T. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 1979;59:606-718.
41. Kondo N, Mizukami M, Shibata S. Negative inotropic effects of disopyramide on guinea-pig papillary muscles. Br J Pharmacol 1990;101:789-92.
42. Rüegg UT, Wallnöfner A, Weir S, Cauvin C. Receptor-operated calcium-permeable channels in vascular smooth muscle. J Cardiovasc Pharmacol 1989;14(suppl 6):S49-55.
43. Bachour G, Hochrein H. Hemodynamic responses to propafenone. Drug Dev Eval 1977;1:39-44.
44. Fernández el Pozo B, Pérez-Vizcaíno F, Villamor E, Zaragozá F, Tamargo J. Stereoselective effects of the enantiomers quinidine and quinine on depolarization and agonist-mediated responses in isolated rat aorta. Br J Pharmacol 1996;117:105-10.
45. Silke B, Frais MA, Verma SP, et al. Comparative haemodynamic effects of intravenous lidocaine, disopyramide, and flecainide in uncomplicated myocardial infarction. Br J Clin Pharmacol 1986;22: 707-14.
46. Niarchos AP. Disopyramide: serum levels and arrhythmia conversion. Am Heart J 1976;92:57-64.
47. Jaeger A, Sauder JD, Tempe JM, Mantz JM. Intoxications aiguës par le disopyramide. Nouv Presse Med 1981;10:2883.